Guelph, Ontario · Founded 2008

A deep science platform
with a new strategy.

Zentek holds a graphite deposit that has demonstrated nuclear-grade purity, a growing patent portfolio, and three structurally distinct commercial platforms: each operating the same client-funded CRO model. New leadership since December 2025 is executing a unified strategy across all three.

What we are
Zentek is a deep science platform company. Industry has a problem, we deliver development-on-demand solutions and own the IP.

We operate three distinct businesses. Albany Graphite, our graphene platform, and Triera Biosciences: on a single governing model: client-funded research and development, with Zentek retaining commercial ownership of every innovation that results. No manufacturing capex. Government grants have the potential to offset a meaningful portion of R&D costs. A patent portfolio that compounds with every engagement.

This model has created multi-billion dollar companies in pharma and specialty materials. Zentek is working to apply this across three platforms simultaneously: at the convergence of critical minerals supply chain urgency, advanced material performance demand, and next-generation therapeutic development.

01

Client-funded R&D

Industry funds the research program. Zentek develops the solution. Potential development fees generate near-term cash before any royalty stream exists.

02

IP ownership

Zentek will seek to retain commercial rights to every innovation developed through client engagements. Government retains only a non-commercial use licence where government funding contributed.

03

Asset-light, high margin

Partners handle production scale-up. No factory. No manufacturing dilution. Potential premium margins on specialized expertise: the same structure that defines the most valuable specialty chemicals and biotech companies.

04

Non-dilutive by design

NRC IRAP, SR&ED, and Ontario OIDMTC have the potential to offset a meaningful portion of R&D costs through non-dilutive funding programs.

The repositioning

An extraordinary set of opportunities.A new unified strategy to connect them.

Since December 2025, Zentek has repositioned from a collection of individual projects into a more unified platform company. Five strategic shifts. One governing model.

01
Lead asset defined
Albany graphite deposit established as the foundational raw material asset: 5N purity, low boron, no halogen contamination based on initial bench-scale testing. Potential to serve mission-critical markets where non-aligned supply is legally or strategically excluded.
02
Processing strategy
Advanced FBR processing centre positioned as a materials provider, not a mine: a potential value-added supplier to nuclear, defense, and aerospace.
03
Coatings reframed
From a product company to a development-on-demand graphene CRO: industry has a problem, we deliver solutions and own the IP. Four verticals, one model.
04
Life sciences crystallised
Triera Biosciences established as a dedicated aptamer CRO: custom discovery, rapid diagnostics, and therapeutic development. The same client-funded IP-ownership model applied to biotech.
05
One story
Zentek as a deep science platform company: validated assets, 25+ patent families, three distinct markets, one governing model.
Leadership team

The team
executing the plan.

Chief Executive Officer
Mohammed (Moe) Jiwan
CEO
Appointed December 1, 2025 with a mandate to reposition Zentek as a coherent deep science platform company, clarify the investment thesis, and execute across three platforms simultaneously. Background in technology and capital markets. Leading the Albany FBR commercialisation pathway, ZenGUARD™ US market development, Triera CRO launch, and capital structure initiatives.
Chief Financial Officer
Wendy Ford
CFO · Financial reporting and capital structure
Oversees financial reporting under IFRS, capital allocation across the three platforms, investor financial communications, and the current capital structure initiatives. Responsible for reconciliation of all financial figures prior to external disclosures, including the company's obligations as a foreign private issuer.
SVP Strategy & Business Development
Ryan Shacklock
SVP Strategy & Business Development
Leads investor relations, strategic communications, and partnership development across all three platforms. Primary point of contact for institutional investors, analysts, and strategic partners. Coordinates across Albany, our graphene platform, and Triera on commercial development activities.
R&D Director
Adam MacIntosh
R&D Director · Research programs
Leads internal R&D activities across our graphene platform and biosciences platforms. Oversees research supply procurement, laboratory operations at the Guelph facility, and collaboration with the McMaster University research team. Primary technical contact for graphene platform CRO engagements and Triera diagnostic development programs.
VP Development · Qualified Person
Peter Wood, P.Eng., P.Geo.
VP Development · NI 43-101 Qualified Person
Designated Qualified Person under National Instrument 43-101: responsible for technical oversight and sign-off of all technical content relating to the Albany Graphite deposit prior to external distribution. Oversees the updated PEA program, environmental baseline work, and Indigenous engagement.
Join Zentek

We build with a small team, deep expertise, and a clear mandate. If you are a scientist, engineer, or operator who wants to work on problems that matter: we want to hear from you.

View open roles →
Company credentials

What makes the platform
credible.

Certified quality management · medical device standard · Guelph, Ontario manufacturing
25+
Patent families across graphene coatings, aptamers, graphite processing and materials
588
Combined team publications · Triera platform researchers · peer-reviewed science
2008
Founded · dual-listed TSX-V: ZEN and Nasdaq: ZTEK · Guelph, Ontario headquarters
Locations
Processing & R&D Lab
Guelph, Ontario
Graphene synthesis · coating application · laboratory testing · 25,000 sq ft
Albany Graphite Deposit
~70 km northwest of Hearst, Ontario
Porcupine Mining District · James Bay lowlands · year-round helicopter access
Research partnerships
McMaster University
Exclusive 20-year aptamer license · 588 combined publications · CL3 biosafety research · electrochemical sensor development · ML classification